Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2022-06-08 Regulatory Filings
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings Classification · 95% confidence The document is a short announcement addressed to the National Stock Exchange of India regarding an agreement between Ajooni Biotech Limited and Harit Pradesh Milk Producer Company Limited for the supply of cattle feed. It contains no financial statements, no regulatory certifications, no voting results, no management or board changes, and no detailed financial or operational data. The document is an update on a business agreement and is brief (1305 characters). It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any detailed financial or governance report. It is a general regulatory announcement about a business update. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-06-08 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions pursuant to Regulation 23(9) of the SEBI Listing Regulations for the half year ended 31 March 2022. It contains detailed tabular data on transactions with related parties such as purchases, sales, leases, and remuneration. The document is not an annual or interim report but a regulatory disclosure specific to related party transactions. It is not a certification or announcement of a report but the actual disclosure itself. This type of document fits best under Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations and does not fall under other more specific categories like Annual Report, Interim Report, or Remuneration Information. The document length (over 14,000 characters) and detailed data support that it is a substantive filing, not just an announcement or certification.
2022-05-27 English
Outcome of Board Meeting
Regulatory Filings
2022-05-09 English
Financial Result Updates
Annual Report Classification · 95% confidence The document contains detailed audited financial results for the year ended 31st March 2022, including standalone financial results, profit and loss statements, and statement of assets and liabilities. It references the approval of audited financial statements by the Board of Directors and includes an auditor's report and declaration of unmodified opinion. The document is comprehensive and contains substantive financial data and analysis for the full fiscal year, consistent with an Annual Report filing. It is not merely an announcement or a certification but includes actual financial statements and audit opinions. Therefore, it fits the definition of an Annual Report (10-K).
2022-05-09 English
Board Meeting — Financial results/Other business matters
Board/Management Information Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting scheduled for May 9, 2022. The agenda includes approval of audited financial results and appointment of a secretarial auditor. It is an announcement of a board meeting rather than the meeting materials or minutes themselves. The document length is only 1289 characters, indicating it is a brief notice. This fits the category of Board/Management Information (MANG), which covers announcements related to board meetings and management changes or appointments. It is not a full financial report or audit report, nor is it a regulatory filing or report publication announcement. Therefore, the correct classification is MANG with high confidence.
2022-04-27 English
General updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India confirming the non-applicability of a statement regarding deviation or variation in the use of IPO proceeds under SEBI regulations. It is a regulatory compliance communication rather than a financial report or detailed filing. The document is short (1161 characters) and serves as an official notification to the exchange. It does not contain financial statements, audit information, or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents.
2022-04-23 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.